And Type 2 Diabetes was an area whose work was led by pharmas much more than biotechs - any biotechs working on it would partner early on with pharma given the following: T2D trials are notoriously large and lengthy, so its valuable for pharma to subsidize that cost T2D drugs will likely need the help of pharma for commercial launch anyways, so partnership is inevitable Its no wonder that the first drug of biotech, Humalin, was partnered with Eli Lilly
Since the bio-based materials used in Ypsomeds devices retain the same chemical properties as conventionalplastics, the transition requires no additional regulatory approvals or manufacturing modifications a key advantage already outlined
Yes, it is normal for eye twitching to worsen during certain times of the day
Injection site discomfort Its common to feel slight pain, warmth, or see redness where the IV drip was inserted
The gut moves slower, and more water is absorbed from the stool, creating hard, difficult-to-pass impactions
They should only be used if prescribed by a healthcare professional and are not recommended for cosmetic weight loss in people who are not overweight or diabetic